Lumos Diagnostics Holdings Pty. Ltd. scooped up AU$25 million (US$17.9 million) in an oversubscribed pre-IPO ahead of its anticipated 2021 listing on the Australian Securities Exchange (ASX). The ...

Key market opportunities in the point-of-care influenza diagnostics market include the rising demand for rapid tests due to ...

Recent advances in portable and automated molecular diagnostic systems will address the previously unmet need for decentralized, point-of-care nucleic acid testing. Rapid, accurate diagnostic systems ...

We discuss here critical factors in ensuring the success of a viral diagnostic at the point of care. Molecular and immunoassay approaches are reviewed with a focus on their ability to meet the ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

Given the possible severity of anthrax infection, early and fast diagnosis is key. InBios International, Inc., a developer of diagnostic tests for emerging infectious diseases and biothreats, has been ...

The market for point-of-care (POC) testing products – such as pregnancy tests and glucose monitoring devices – is currently growing at a rate of 6 percent per year, said a new report from healthcare ...

BOSTON--(BUSINESS WIRE)--binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced key findings from a new Massachusetts General ...